Michael R Hayden Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael R Hayden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael R Hayden. Michael R Hayden is a Director in IONIS PHARMACEUTICALS INC ($ISIS) and a Director in Xenon Pharmaceuticals Inc. ($XENE) and a Director in Aurinia Pharmaceuticals Inc. ($AUPH) and a Director in AbCellera Biologics Inc. ($ABCL) and a Director in 89bio, Inc. ($ETNB).
Address: C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY V5G 4W8 A1
Companies in which Michael R Hayden is an Insider
89bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 60,820 shares
Latest Transaction: Apr 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AbCellera Biologics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 985,750 shares
Latest Transaction: Dec 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aurinia Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 50,000 shares
Latest Transaction: Feb 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IONIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 5,334 shares
Latest Transaction: Oct 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xenon Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael R Hayden: Director
Holdings: 50,924 shares
Current Value: $417,577
Latest Transaction: Jun 02 2020
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael R Hayden
Sentiment: All, ETNB, ABCL, AUPH, ISIS, XENE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Apr 19 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | A | 24.16 | 12,500 | 302,000 | 12,500 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 3.11 | 13,637 | 42,411 | 22,730 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 1.93 | 6,447 | 12,443 | 2,933 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | M | 1.93 | 60,820 | 117,383 | 27,647 | |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | M | 3.11 | 13,637 | 42,411 | 80,904 | 67.3 K to 80.9 K (+20.27 %) |
| Feb 25 2021 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | M | 1.93 | 6,447 | 12,443 | 67,267 | 60.8 K to 67.3 K (+10.60 %) |